» Articles » PMID: 21981058

Essential, but at What Risk? A Prospective Study on Central Venous Access in Patients with Haematological Malignancies

Overview
Journal Intern Med J
Specialty General Medicine
Date 2011 Oct 11
PMID 21981058
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Central venous catheters (CVC) are integral to modern haematology practice; however, they are associated with a range of complications. This prospective study aimed to determine the rate of CVC-related complications and risk factors in haematology patients, who are vulnerable because of their underlying pathology and treatments.

Methods: All inpatients that had a non-tunnelled CVC inserted in a 14-month period in the haematology ward at St Vincent's Hospital were enrolled. Complications (immediate and late), demographics, type of device, insertion technique and duration of dwell, were examined using multivariate analysis.

Results: One hundred and seventy-four CVC in 84 patients were recorded, representing 3016 catheter-days. At least one complication was found in 43 (24.7%) patients. Immediate complications occurred in 13 (7.5%) insertions, with a higher rate in those inserted after ≥2 attempts compared with one (P = 0.02). Catheter-related bloodstream infection occurred at a rate of 7.6 per 1000 catheter-days, with acute lymphoblastic leukaemia associated with a higher rate (P = 0.02), and subclavian vein CVC had a lower rate compared with other locations (P < 0.01). Thrombosis was found in seven (4.0%) patients, with subclavian CVC carrying an increased risk (P = 0.02).

Conclusions: This prospective observational study found almost a quarter of haematology patients experience a CVC-related complication. An association was found with a number of attempts at insertion and immediate complications; other risk factors included anatomical location, underlying disease and duration of catheterisation. The relatively high complication rate, compared with reports of non-haematology patients, highlights the need to improve CVC management, a vital part of care for this population.

Citing Articles

Incidence of Catheter-Associated Bloodstream Infections in Stem Cell Recipients-Should We Be "PICCy"?.

Milczarek S, Kulig P, Piotrowska O, Zuchmanska A, Wilk-Milczarek E, Machalinski B Cancers (Basel). 2024; 16(6).

PMID: 38539571 PMC: 10969275. DOI: 10.3390/cancers16061239.


Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study.

Picardi M, Giordano C, Pepa R, Pugliese N, Esposito M, Abagnale D Cancers (Basel). 2023; 15(7).

PMID: 37046808 PMC: 10093126. DOI: 10.3390/cancers15072147.


Changes in Central Venous Catheter Use in the Hematology Unit with the Introduction of Ultrasound Guidance and a Peripherally Inserted Central Venous Catheter.

Utsu Y, Masuda S, Watanabe R, Arai H, Nakamura A, Matsui S Intern Med. 2021; 60(17):2765-2770.

PMID: 34470985 PMC: 8479208. DOI: 10.2169/internalmedicine.7119-21.


Venue of catheter insertion does not significantly impact the event of central line-associated bloodstream infection in patients with haematological diseases.

Kitamura H, Kubota Y, Komukai S, Yoshida H, Kaneko Y, Mihara Y Infect Prev Pract. 2021; 2(2):100050.

PMID: 34368700 PMC: 8336171. DOI: 10.1016/j.infpip.2020.100050.


Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy.

Rixecker T, Lesan V, Ahlgrimm M, Thurner L, Bewarder M, Murawski N Bone Marrow Transplant. 2020; 56(1):195-201.

PMID: 32704092 DOI: 10.1038/s41409-020-01003-0.